ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada
· Delayed Price · Currency is CAD 0.700
0.00 (0.00%)
At close: Dec 5, 2025
ZYUS Life Sciences Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 0.47 | 0.48 | 0.35 | 0.3 | 0.21 | - |
| Revenue Growth (YoY) | 2.88% | 37.04% | 17.79% | 43.96% | - | - |
| Cost of Revenue | 1.49 | 1.44 | 2.36 | 0.94 | 0.06 | - |
| Gross Profit | -1.03 | -0.96 | -2.01 | -0.64 | 0.14 | - |
| Selling, General & Admin | 8.15 | 8.92 | 12.33 | 9.34 | 12.48 | 14.18 |
| Research & Development | 2.04 | 2.05 | 1.31 | 2.21 | 5.37 | 4.51 |
| Other Operating Expenses | 0.4 | 0.49 | 0.35 | 0.37 | 0.66 | 0.18 |
| Operating Expenses | 13.69 | 14.83 | 17.36 | 16.06 | 22.91 | 22.25 |
| Operating Income | -14.72 | -15.79 | -19.37 | -16.7 | -22.77 | -22.25 |
| Interest Expense | -1.59 | -0.76 | -3.27 | -5.24 | -1.46 | -0.67 |
| Interest & Investment Income | 0.11 | 0.26 | 0.7 | 0.22 | - | - |
| Currency Exchange Gain (Loss) | -0.03 | -0.09 | -0.08 | -0.01 | -0.07 | -0.02 |
| Other Non Operating Income (Expenses) | -0.38 | -0.32 | -3.65 | -0.88 | 0.73 | 0.6 |
| EBT Excluding Unusual Items | -16.6 | -16.69 | -25.67 | -22.62 | -23.57 | -22.34 |
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.24 |
| Asset Writedown | -19.2 | -19.2 | -22.77 | -2.09 | - | -3.25 |
| Pretax Income | -35.78 | -35.89 | -48.44 | -24.72 | -23.57 | -25.35 |
| Income Tax Expense | -2.04 | -2.09 | -5.85 | -0.06 | -0.12 | -0.26 |
| Net Income | -33.74 | -33.81 | -42.59 | -24.66 | -23.46 | -25.09 |
| Net Income to Common | -33.74 | -33.81 | -42.59 | -24.66 | -23.46 | -25.09 |
| Shares Outstanding (Basic) | 76 | 72 | 56 | 38 | 51 | 49 |
| Shares Outstanding (Diluted) | 76 | 72 | 56 | 38 | 51 | 49 |
| Shares Change (YoY) | 6.48% | 28.41% | 45.82% | -24.99% | 5.35% | - |
| EPS (Basic) | -0.45 | -0.47 | -0.76 | -0.64 | -0.46 | -0.52 |
| EPS (Diluted) | -0.45 | -0.47 | -0.76 | -0.64 | -0.46 | -0.52 |
| Free Cash Flow | -10.74 | -9.92 | -18.23 | -10.13 | -21.85 | -26.13 |
| Free Cash Flow Per Share | -0.14 | -0.14 | -0.33 | -0.26 | -0.43 | -0.54 |
| Gross Margin | -220.86% | -199.38% | - | -214.09% | 69.08% | - |
| Operating Margin | -3165.38% | -3282.33% | -5519.37% | -5604.36% | -10999.52% | - |
| Profit Margin | -7256.77% | -7028.07% | -12134.19% | -8274.16% | -11330.92% | - |
| Free Cash Flow Margin | -2309.46% | -2062.79% | -5193.45% | -3400.67% | -10553.14% | - |
| EBITDA | -12.29 | -13.29 | -16.67 | -14.09 | -20.64 | -21.19 |
| D&A For EBITDA | 2.43 | 2.5 | 2.7 | 2.61 | 2.13 | 1.06 |
| EBIT | -14.72 | -15.79 | -19.37 | -16.7 | -22.77 | -22.25 |
Source: S&P Capital IQ. Standard template. Financial Sources.